Calyxt achieves phase 1 milestone in collaboration agreement to develop alternative to palm oil

Roseville, minn. , nov. 18, 2022 /prnewswire/ -- calyxt, inc. (nasdaq: clxt), a plant-based synthetic biology company announced today that it has successfully completed the first phase in its research collaboration agreement with a leading global food ingredient manufacturer based in asia to develop an improved soybean capable of producing an oil as a commercial alternative to palm oil.
CLXT Ratings Summary
CLXT Quant Ranking